MSF fumes over HIV drug

news-image

Colleta Dewa

 

Johannesburg - Doctors Without Borders (MSF) is up in arms with Gilead Sciences, a US pharmaceutical corporation, accusing it of failing to fulfil its promise to make available an important drug that treats cryptococcal meningitis to people suffering from a life-threatening HIV-related infection.

MSF told The Southern Times that they want Gilead to honour its commitment, to prove its promise was more than just a public relations stunt.

According to MSF, Gilead announced its “access initiative” promising lower prices for the liposomal amphotericin B (L-AmB) drug in 116 developing countries in September 2018, but to date, it largely remains inaccessible.

 MSF said the pharmaceutical corporation registered the drug in only six of the 116 countries, and even where it is registered, the drug is unavailable at an affordable price for MSF and others.

The six countries include South Africa, Bangladesh, Bolivia, Ethiopia, India, and Thailand.

Although Gilead publicised their pledge to reduce the price of L-AmB to a “no-profit” price of US$16.25 (R233.21) per vial, the drug continues to be overpriced in many developing countries.

In South Africa, the drug is priced as high as US$200 or R2 870.27 per vial (at least $4,200 or R60 275.67 per full treatment course). In India, it is priced at $45 or R645.81 per vial (nearly $1,000 or R 14 351.35 per full treatment course). The full treatment course is typically seven days long.

MSF said national programmes and treatment providers were still unable to purchase the drug at the corporation’s promised price although Gilead continues to earn billions of dollars each year from global HIV drug sales.

The corporation reported US$14.6 billion in sales from global HIV drugs in 2018 alone.

“We are outraged that Gilead’s announcement to provide this lifesaving drug at a supposed ‘no profit’ price and expedite its registration appears to have been nothing more than a public relations stunt. The corporation has failed to make good on their promise to do more to help ensure the survival of people living with HIV affected by this deadly disease – it’s deplorable that they keep dragging their feet at the expense of peoples’ lives. Gilead must urgently honour their commitment to make L-AmB available for everyone who needs it, and quickly register the drug in high HIV-burden countries,” said Jessica Burry, MSF pharmacist.

L‑AmB is highly effective when used in combination with other medicines to treat cryptococcal meningitis, which is the second biggest killer of people living with HIV, after tuberculosis.

Cryptococcal meningitis is an infection of the brain, which if left untreated, results in an agonising death for people living with HIV. It kills more than 180,000 people every year, 75% of whom live in sub-Saharan Africa.

 It especially affects people living with HIV whose immune systems are severely suppressed, leaving them vulnerable to such deadly opportunistic infections.

 MSF says it treats the infection in all its HIV programmes, including in the Democratic Republic of Congo, India, Malawi, Myanmar and South Africa.

 

LEAVE A COMMENT

Comments

Be with us

  • 230500likes
  • 748subscribers
  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 1

    Filename: includes/right_side.php

    Line Number: 211

    Backtrace:

    File: /var/www/html/application/views/frontend/includes/right_side.php
    Line: 211
    Function: _error_handler

    File: /var/www/html/application/views/frontend/includes/right_side.php
    Line: 216
    Function: scrape_insta

    File: /var/www/html/application/views/frontend/site/news_template/First.php
    Line: 142
    Function: view

    File: /var/www/html/application/views/frontend/includes/template1.php
    Line: 3
    Function: view

    File: /var/www/html/application/controllers/Site.php
    Line: 413
    Function: view

    File: /var/www/html/index.php
    Line: 316
    Function: require_once

  • 13comments
image

Poachers have broken into Botswana’s p Read more...

10 Aug, 2018 at 01:58 PM

image

In a sign that Botswana is likely to cli Read more...

02 Jul, 2018 at 09:26 AM

image

DAR ES SALAAM - DIRECTIVES on online for Read more...

02 Jul, 2018 at 01:24 PM

image

Gaborone - Poachers have broken into Bot Read more...

04 Feb, 2019 at 07:35 AM

image

Gaborone – The Botswana government has Read more...

25 May, 2018 at 02:35 PM

image

Dares Salaam - The Southern African Deve Read more...

20 Aug, 2019 at 12:03 PM

image

Dar es Salaam – Outgoing Southern Afri Read more...

20 Aug, 2019 at 11:58 AM

image

Lusaka - Africa risks veering off course Read more...

20 Aug, 2019 at 11:43 AM

image

Gaborone - The SADC Secretariat convened Read more...

20 Aug, 2019 at 11:41 AM

image

Gaborone - Despite poverty eradication b Read more...

20 Aug, 2019 at 11:26 AM

image

Miss Namibia crowned Read more...

20 Mar, 2018 at 05:50 AM

image

Lusaka - Amid myriad criticisms from soc Read more...

14 Dec, 2018 at 06:28 AM

image

Windhoek - Tanzania has been outperformi Read more...

24 Sep, 2018 at 09:29 AM

image

Heads of state and ministers who travell Read more...

30 Jul, 2018 at 02:01 PM

image

Windhoek - The European Union National I Read more...

01 Apr, 2019 at 12:33 PM